Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SEATTLE, March 16, 2011 (GLOBE NEWSWIRE) -- The article (http://www.cpreports.com/?p=931), written by respected business writer Gene Marcial, provides insights into recent progress of TapImmune Inc....
-
SEATTLE, March 4, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), wishes to provide a clarification to the Press Release issued on March 1, 2011 'TapImmune Closes $1.16 Million Funding'. We...
-
SEATTLE, March 1, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) is pleased to announce the closing of a $1.16M funding. On February 24, 2011, we entered into a securities purchase agreement...
-
SEATTLE, Oct. 14, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV). Over the last 12 months we have made significant progress in moving TapImmune and its technology platform toward the clinic....
-
SEATTLE, Sept. 8, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) is pleased to announce the following appointment to its Board of Directors: Lynn M. DePippo, Founder and Managing Partner,...
-
SEATTLE, Aug. 4, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) announced that it has signed a Research and Technology License Option Agreement with Mayo Clinic, Rochester, MN, for the...
-
BELLEVUE, Wash., June 1, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) announced that it has signed an exclusive Licensing Option agreement with Mayo Clinic, Rochester, MN, for clinical...
-
BELLEVUE, Wash., May 24, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV) announced today that the Company has completed the sale of Senior Secured Convertible Notes ("Notes") totaling $1.53...
-
BELLEVUE, Wash., May 18, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), a Nevada corporation, announced today that the Company entered into a definitive purchase agreement on May 17, 2010 with...
-
BELLEVUE, Wash., Feb. 23, 2010 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), is pleased to provide this corporate update to our shareholders and other interested parties. With 2010 now out of the...